- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0162169

Li Shanto Pharmaceuticals Private Limited
About Li Shanto Pharmaceuticals Private Limited
Data last updated:
Li Shanto Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24304PN2020PTC193291. Its GSTIN is 20AAECL3091K1ZN (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Birendra Kumar Singh (Managing Director) and Akash Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S. No. 5/4 F. No. 604B Tara Angan Keshav Nagar Pune Maharastra – 411036, Maharashtra, India – 411036.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.53 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹91,355 (net margin 0.6%) and EBITDA of ₹6.45 Lakh (EBITDA margin 4.2%).
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Li Shanto Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0162169).
Company details
Recognitions & Rankings of Li Shanto Pharmaceuticals
Contact details
Li Shanto Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS. No. 5/4 F. No. 604B Tara Angan Keshav Nagar Pune Maharastra – 411036, Maharashtra, India – 411036
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Li Shanto Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Li Shanto Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Li Shanto Pharmaceuticals Private Limited, buy the company report.
Financials of Li Shanto Pharmaceuticals Private Limited
FY 2025 filings availableLi Shanto Pharmaceuticals Private Limited reported revenue of ₹1.53 Cr (down 22% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹6.45 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹91,355 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.2% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Li Shanto Pharmaceuticals Private Limited, buy the company report.
Board of directors of Li Shanto Pharmaceuticals Private Limited
Li Shanto Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akash Kumar | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Vikash Kumar Singh | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Birendra Kumar Singh | Managing Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Sanjeev Kumar | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Li Shanto Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kript Pharmaceuticals Private Limited | ₹1.54 Cr (FY 2025) | -19.0% | Kurukshetra, Haryana, India | |||
| Li Shanto Pharmaceuticals Private Limitedthis company | ₹1.53 Cr (FY 2024) | ₹91,355 | 0.6% | -22.0% | Pune, Maharashtra, India | |
| Shree Vishwamitra Ayurved Pharmaceuticals Private Limited | ₹1.53 Cr (FY 2025) | 10.0% | Ahmedabad, Gujarat, India | |||
| Sahana Pharmaceuticals Private Limited | ₹1.52 Cr (FY 2025) | 41.0% | Nagercoil, Tamil Nadu, India |
To see the full peer comparison of Li Shanto Pharmaceuticals Private Limited, buy the company report.
Auditor
Li Shanto Pharmaceuticals Private Limited is audited by D. K. Verma & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D. K. Verma & Associates | FY 2023 | 326227E |
Shareholding
The shareholding of Li Shanto Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Li Shanto Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Feb 2022 | 100557479 | Canara Bank | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Li Shanto Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Li Shanto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Li Shanto Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Li Shanto Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAECL3091K1ZN | Jharkhand | Active | 28 May 2021 |
To see the full GST registrations and return filing status of Li Shanto Pharmaceuticals Private Limited, buy the company report.
Recent activity
Li Shanto Pharmaceuticals Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Akash Kumar was appointed as Director on 24 Aug 2020.
Frequently asked questions
Li Shanto Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 August 2020 (6+ years old) and is registered under CIN U24304PN2020PTC193291.
Li Shanto Pharmaceuticals has 4 current directors:
- Birendra Kumar Singh - Managing Director
- Akash Kumar - Director
- Vikash Kumar Singh - Director
- Sanjeev Kumar - Director
The latest financial statements of Li Shanto Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Li Shanto Pharmaceuticals is 20AAECL3091K1ZN, registered in Jharkhand.
The CIN (Corporate Identification Number) of Li Shanto Pharmaceuticals is U24304PN2020PTC193291. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Li Shanto Pharmaceuticals was incorporated on 24 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Li Shanto Pharmaceuticals by revenue are Kript Pharmaceuticals Private Limited, Shree Vishwamitra Ayurved Pharmaceuticals Private Limited, Sahana Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Akash Kumar was appointed as Director on 24 Aug 2020. Birendra Kumar Singh was appointed as Managing Director on 24 Aug 2020. Sanjeev Kumar was appointed as Director on 24 Aug 2020. Li Shanto Pharmaceuticals has 4 board changes on record in total.
Yes, Li Shanto Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0162169).
The registered office of Li Shanto Pharmaceuticals is at S. No. 54 F. No. 604B Tara Angan Keshav Nagar Pune Maharastra – 411036, Maharashtra, India – 411036.
Li Shanto Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

